Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2, Open-label, Multicenter Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

NCT07116616 is registered in ClinicalTrials.gov with ModernaTX, Inc. as lead sponsor.

NCT NCT07116616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07116616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2, Open-label, Multicenter Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
Lead sponsor
ModernaTX, Inc.
Phase
Phase 1/2
Overall status
Recruiting
Start date
September 30, 2025
Completion date
June 17, 2032
Enrollment
190 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed or refractory multiple myeloma